Metropolitan Life Insurance Co NY decreased its position in MAXIMUS, Inc. (NYSE:MMS) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 36,425 shares of the health services provider’s stock after selling 430 shares during the period. Metropolitan Life Insurance Co NY’s holdings in MAXIMUS were worth $2,814,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Advisory Services Network LLC increased its holdings in shares of MAXIMUS by 499.0% during the second quarter. Advisory Services Network LLC now owns 593 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 494 shares during the period. Quantamental Technologies LLC bought a new stake in shares of MAXIMUS during the second quarter valued at about $71,000. Signaturefd LLC lifted its holdings in MAXIMUS by 19.6% in the second quarter. Signaturefd LLC now owns 1,145 shares of the health services provider’s stock worth $83,000 after purchasing an additional 188 shares during the period. Coastal Investment Advisors Inc. acquired a new stake in MAXIMUS in the third quarter worth about $103,000. Finally, Tower Research Capital LLC TRC lifted its holdings in MAXIMUS by 70.8% in the second quarter. Tower Research Capital LLC TRC now owns 1,500 shares of the health services provider’s stock worth $109,000 after purchasing an additional 622 shares during the period. Institutional investors own 94.95% of the company’s stock.

MMS opened at $74.15 on Tuesday. The business has a 50 day moving average price of $75.74 and a two-hundred day moving average price of $75.20. The company has a market capitalization of $4.78 billion, a price-to-earnings ratio of 19.93, a price-to-earnings-growth ratio of 1.84 and a beta of 0.79. MAXIMUS, Inc. has a 1-year low of $62.00 and a 1-year high of $82.02.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Tuesday, November 19th. The health services provider reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.01). MAXIMUS had a net margin of 8.34% and a return on equity of 21.09%. The firm had revenue of $754.97 million for the quarter, compared to analyst estimates of $756.40 million. During the same quarter last year, the business posted $0.71 earnings per share. The firm’s revenue for the quarter was up 35.2% compared to the same quarter last year. As a group, research analysts predict that MAXIMUS, Inc. will post 4.05 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a dividend of $0.28 per share. The ex-dividend date of this dividend was Thursday, November 14th. This represents a $1.12 annualized dividend and a yield of 1.51%. This is a boost from MAXIMUS’s previous quarterly dividend of $0.25. MAXIMUS’s dividend payout ratio (DPR) is currently 30.11%.

Several equities analysts have commented on the stock. ValuEngine raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a research note on Friday, October 25th. Canaccord Genuity upped their price target on shares of MAXIMUS from $72.00 to $77.00 and gave the stock a “hold” rating in a research note on Tuesday, August 13th. Finally, Wells Fargo & Co reiterated a “market perform” rating and issued a $83.00 price objective on shares of MAXIMUS in a report on Friday, August 9th.

In related news, Director Raymond B. Ruddy sold 25,000 shares of the stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $79.89, for a total transaction of $1,997,250.00. Following the completion of the sale, the director now directly owns 156,852 shares of the company’s stock, valued at $12,530,906.28. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, General Counsel David Francis sold 6,496 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $77.43, for a total transaction of $502,985.28. The disclosure for this sale can be found here. Insiders have sold 55,496 shares of company stock valued at $4,398,575 in the last ninety days. Company insiders own 2.20% of the company’s stock.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Read More: Correction

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.